NOS3, nitric oxide synthase 3, 4846

N. diseases: 706; N. variants: 39
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0920563
Disease: Insulin Sensitivity
Insulin Sensitivity
0.300 Biomarker phenotype CTD_human Increased endothelial nitric-oxide synthase expression reduces hypertension and hyperinsulinemia in fructose-treated rats. 19008412 2009
CUI: C0920563
Disease: Insulin Sensitivity
Insulin Sensitivity
0.300 Therapeutic phenotype CTD_human Increased endothelial nitric-oxide synthase expression reduces hypertension and hyperinsulinemia in fructose-treated rats. 19008412 2009
CUI: C0920563
Disease: Insulin Sensitivity
Insulin Sensitivity
0.300 Therapeutic phenotype CTD_human Endothelial nitric oxide synthase polymorphisms are associated with type 2 diabetes and the insulin resistance syndrome. 12716763 2003
CUI: C0920563
Disease: Insulin Sensitivity
Insulin Sensitivity
0.300 Therapeutic phenotype CTD_human In addition to arterial pressure and insulin sensitivity (euglycaemic hyperinsulinaemic clamp), we measured the plasma concentration of leptin, insulin, cholesterol, triglycerides, free fatty acids, fibrinogen and uric acid in 10 to 12 week old eNOS-/- and wild type mice. 12947532 2003
CUI: C0920563
Disease: Insulin Sensitivity
Insulin Sensitivity
0.300 Biomarker phenotype CTD_human In addition to arterial pressure and insulin sensitivity (euglycaemic hyperinsulinaemic clamp), we measured the plasma concentration of leptin, insulin, cholesterol, triglycerides, free fatty acids, fibrinogen and uric acid in 10 to 12 week old eNOS-/- and wild type mice. 12947532 2003
CUI: C0920563
Disease: Insulin Sensitivity
Insulin Sensitivity
0.300 Biomarker phenotype CTD_human Endothelial nitric oxide synthase polymorphisms are associated with type 2 diabetes and the insulin resistance syndrome. 12716763 2003
CUI: C0920563
Disease: Insulin Sensitivity
Insulin Sensitivity
0.300 Biomarker phenotype CTD_human To study the role of eNOS in the control of the metabolic action of insulin, we assessed insulin sensitivity in conscious mice with disruption of the gene encoding for eNOS. eNOS(-/-) mice were hypertensive and had fasting hyperinsulinemia, hyperlipidemia, and a 40% lower insulin-stimulated glucose uptake than control mice. 11457755 2001
CUI: C0920563
Disease: Insulin Sensitivity
Insulin Sensitivity
0.300 Therapeutic phenotype CTD_human To study the role of eNOS in the control of the metabolic action of insulin, we assessed insulin sensitivity in conscious mice with disruption of the gene encoding for eNOS. eNOS(-/-) mice were hypertensive and had fasting hyperinsulinemia, hyperlipidemia, and a 40% lower insulin-stimulated glucose uptake than control mice. 11457755 2001